Portfolio company MRM Health was granted FDA Fast Track designation for its lead asset MH002.
MRM Health is a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based Live Biotherapeutic Products for chronic diseases with high unmet needs, utilizing their proprietary CORAL® platform
MRM Health is a clinical-stage biopharmaceutical company focused on developing innovative microbiome-based Live Biotherapeutic Products for chronic diseases with high unmet needs, utilizing their proprietary CORAL® platform.